| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $345.0M | +182.3% |
| SG&A Expense | $39.6M | +36.7% |
| Operating Income | -$384.7M | -154.4% |
| Interest Expense | $5.3M | +10.3% |
| Pre-tax Income | -$366.4M | -164.9% |
| Income Tax | $692K | -82.1% |
| Net Income | -$367.1M | -158.2% |
| EPS (Basic) | -$3.51 | -75.5% |
| EPS (Diluted) | -$3.51 | -75.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $126.1M | -60.1% |
| Short-term Investments | $313.9M | +19.5% |
| Current Assets | $476.4M | -19.7% |
| Total Assets | $478.7M | -19.7% |
| Current Liabilities | $36.1M | +22.0% |
| Long-term Debt | $35.7M | +44.1% |
| Total Liabilities | $77.9M | +29.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$367.8M | -184.7% |
| Capital Expenditures | $15K | +275.0% |
| Investing Cash Flow | -$40.9M | +66.8% |
| Financing Cash Flow | $218.6M | -57.4% |
| Free Cash Flow | -$367.8M | -184.7% |
| Stockholders' Equity |
| $400.8M |
| -25.3% |